These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6656768)

  • 1. Antigenic, electrophoretic and binding alterations of human C-reactive protein modified selectively in the absence of calcium.
    Potempa LA; Maldonado BA; Laurent P; Zemel ES; Gewurz H
    Mol Immunol; 1983 Nov; 20(11):1165-75. PubMed ID: 6656768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression, detection and assay of a neoantigen (Neo-CRP) associated with a free, human C-reactive protein subunit.
    Potempa LA; Siegel JN; Fiedel BA; Potempa RT; Gewurz H
    Mol Immunol; 1987 May; 24(5):531-41. PubMed ID: 2443837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding reactivity of C-reactive protein for polycations. II. Modulatory effects of calcium and phosphocholine.
    Potempa LA; Siegel JN; Gewurz H
    J Immunol; 1981 Oct; 127(4):1509-14. PubMed ID: 7276568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and partial characterization of multiple native and neoantigenic epitopes of human C-reactive protein by using monoclonal antibodies.
    Ying SC; Gewurz H; Kinoshita CM; Potempa LA; Siegel JN
    J Immunol; 1989 Jul; 143(1):221-8. PubMed ID: 2471736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elucidation of a protease-sensitive site involved in the binding of calcium to C-reactive protein.
    Kinoshita CM; Ying SC; Hugli TE; Siegel JN; Potempa LA; Jiang H; Houghten RA; Gewurz H
    Biochemistry; 1989 Dec; 28(25):9840-8. PubMed ID: 2692716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-reactive protein and the acute phase response.
    Gewurz H; Mold C; Siegel J; Fiedel B
    Adv Intern Med; 1982; 27():345-72. PubMed ID: 7041546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conversion of native oligomeric to a modified monomeric form of human C-reactive protein.
    Kresl JJ; Potempa LA; Anderson BE
    Int J Biochem Cell Biol; 1998 Dec; 30(12):1415-26. PubMed ID: 9924810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferential expression of neo-CRP epitopes on the surface of human peripheral blood lymphocytes.
    Samberg NL; Bray RA; Gewurz H; Landay AL; Potempa LA
    Cell Immunol; 1988 Oct; 116(1):86-98. PubMed ID: 2458846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monomeric C-Reactive Protein in Serum With Markedly Elevated CRP Levels Shares Common Calcium-Dependent Ligand Binding Properties With an
    Williams RD; Moran JA; Fryer AA; Littlejohn JR; Williams HM; Greenhough TJ; Shrive AK
    Front Immunol; 2020; 11():115. PubMed ID: 32117266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The electrophoretically 'slow' and 'fast' forms of the alpha 2-macroglobulin molecule.
    Barrett AJ; Brown MA; Sayers CA
    Biochem J; 1979 Aug; 181(2):401-18. PubMed ID: 91367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of very low density lipoproteins (VLDL) with rabbit C-reactive protein.
    Cabana VG; Gewurz H; Siegel JN
    J Immunol; 1982 May; 128(5):2342-8. PubMed ID: 6801137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential interference of
    Stein CDS; Cassol JPE; Moresco RN
    Scand J Clin Lab Invest; 2023 May; 83(3):183-186. PubMed ID: 37014127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of heparin on interactions between C-reactive protein and polycations.
    Potempa LA; Gewurz H
    Mol Immunol; 1983 May; 20(5):501-9. PubMed ID: 6877243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and functional comparison of native pentameric, denatured monomeric and biotinylated C-reactive protein.
    Taylor KE; van den Berg CW
    Immunology; 2007 Mar; 120(3):404-11. PubMed ID: 17163961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of human neutrophils, monocytes, and platelets by modified C-reactive protein (CRP) expressing a neoantigenic specificity.
    Potempa LA; Zeller JM; Fiedel BA; Kinoshita CM; Gewurz H
    Inflammation; 1988 Aug; 12(4):391-405. PubMed ID: 2459061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-reactivity between C-reactive protein and idiotypic determinants on A phosphocholine-binding murine myeloma protein.
    Volanakis JE; Kearney JF
    J Exp Med; 1981 Jun; 153(6):1604-14. PubMed ID: 6166719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the interactions between C-reactive protein and complement proteins.
    Bíró A; Rovó Z; Papp D; Cervenak L; Varga L; Füst G; Thielens NM; Arlaud GJ; Prohászka Z
    Immunology; 2007 May; 121(1):40-50. PubMed ID: 17244159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Energetics of intersubunit and intrasubunit interactions of Escherichia coli adenosine cyclic 3',5'-phosphate receptor protein.
    Cheng X; Gonzalez ML; Lee JC
    Biochemistry; 1993 Aug; 32(32):8130-9. PubMed ID: 8394127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defined chemically cross-linked oligomers of human C-reactive protein: characterization and reactivity with the complement system.
    Jiang H; Lint TF; Gewurz H
    Immunology; 1991 Dec; 74(4):725-31. PubMed ID: 1783430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Native pentameric C-reactive protein displays more potent pro-atherogenic activities in human aortic endothelial cells than modified C-reactive protein.
    Devaraj S; Venugopal S; Jialal I
    Atherosclerosis; 2006 Jan; 184(1):48-52. PubMed ID: 15894319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.